Literature DB >> 23209

Further studies on the cardiolipin phosphodiesterase of Escherichia coli.

R Cole, P Proulx.   

Abstract

The cardiolipin phosphodiesterase of Escherichia coli was further characterized. This enzyme has a pH optimum of 7.0 and is Mg2+ dependent. Mn2+ and Co2+ could replace Mg2+ but other divalent cations were inhibitory or without effect. The enzyme is not periplasmic and does not appear to be associated with membrane fractions prepared by different methods. It is recovered as a soluble protein in the cytosol fraction but could not be readily purified because of its instability. With cell-free systems, a requirement for ATP or ADP could be shown under certain defined conditions. Other nucleotides were less effective or ineffective in stimulating the phosphodiesterase. The cells displayed the highest activity during the middle to late exponential stage but no marked requirement for ATP was apparent when the phosphodiesterase was obtained from such freshly grown cells. If, however, cells were starved for several hours in saline medium, the cardiolipin phosphodiesterase level fell and a requirement for added ATP could be shown. The cardiolipin phosphodiesterase is an enzyme distinct from cardiolipin synthase. The assay conditions are quite different from each of these enzymes as are their subcellular distributions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 23209     DOI: 10.1139/o77-183

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  3 in total

1.  Enzymology, genetics, and regulation of membrane phospholipid synthesis in Escherichia coli.

Authors:  C R Raetz
Journal:  Microbiol Rev       Date:  1978-09

2.  Phosphatidylethanolamine domains and localization of phospholipid synthases in Bacillus subtilis membranes.

Authors:  Ayako Nishibori; Jin Kusaka; Hiroshi Hara; Masato Umeda; Kouji Matsumoto
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

3.  Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.

Authors:  Robert Root-Bernstein; Jack Huber; Alison Ziehl
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.